tiprankstipranks
Anixa Biosciences Inc (ANIX)
NASDAQ:ANIX

Anixa Biosciences (ANIX) Financial Statements

376 Followers

Anixa Biosciences Financial Overview

Anixa Biosciences's market cap is currently ―. The company's EPS TTM is $-0.369; its P/E ratio is -8.71; Anixa Biosciences is scheduled to report earnings on March 8, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Apr 24Jan 24Oct 23Jul 23Apr 23
Income Statement-
Total Revenue----$ 210.00K
Gross Profit-$ -3.61M$ 5.40M$ -2.84M$ 210.00K
EBIT$ -3.14M$ -3.61M$ -2.72M$ -2.55M$ 3.23M
EBITDA$ -3.13M$ -3.60M$ -2.71M$ -2.54M$ 3.25M
Net Income Common Stockholders$ -3.14M$ -3.25M$ -2.69M$ -2.51M$ 3.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.24M$ 23.80M$ 23.84M$ 25.53M$ 26.98M
Total Assets$ 24.36M$ 25.37M$ 25.52M$ 26.58M$ 27.60M
Total Debt$ 149.00K$ 162.00K$ 175.00K$ 187.00K$ 198.00K
Net Debt$ -23.09M$ -23.64M$ -23.67M$ -25.35M$ -26.78M
Total Liabilities$ 1.77M$ 1.77M$ 2.15M$ 1.99M$ 1.69M
Stockholders Equity$ 23.62M$ 24.61M$ 24.34M$ 25.52M$ 26.81M
Cash Flow-
Free Cash Flow$ -1.46M$ -2.31M$ -1.97M$ -1.45M$ -807.00K
Operating Cash Flow$ -1.46M$ -2.31M$ -1.97M$ -1.45M$ -807.00K
Investing Cash Flow$ 556.00K$ 129.00K$ -593.00K$ -980.00K$ -3.44M
Financing Cash Flow$ 897.00K$ 2.26M$ 279.00K$ 3.00K$ 81.00K
Currency in USD

Anixa Biosciences Earnings and Revenue History

Anixa Biosciences Debt to Assets

Anixa Biosciences Cash Flow

Anixa Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis